Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomous Regulatory Monocytes (OPM Cells) for the Treatment of Diabetic Foot in a Single-arm Open-label Clinical Study

NCT06621303 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT06621303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06621303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomous Regulatory Monocytes (OPM Cells) for the Treatment of Diabetic Foot in a Single-arm Open-label Clinical Study
Lead sponsor
Shanghai East Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
October 31, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer